Literature DB >> 30241261

How Should Genetic Counseling for Ovarian Cancer Be Implemented in a Middle-Income Country? An Insight Based on the Brazilian Scenario.

Maria Aparecida Azevedo Koike Folgueira1, Simone Maistro1, Natalia Teixeira1, Marian J E Mourits1, Roger Chammas1, Geertruida Hendrika de Bock1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30241261      PMCID： PMC6223469          DOI： 10.1200/JGO.17.00230

Source DB:  PubMed          Journal:  J Glob Oncol        ISSN： 2378-9506


× No keyword cloud information.
  6 in total

1.  Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.

Authors:  Tom Walsh; Silvia Casadei; Ming K Lee; Christopher C Pennil; Alex S Nord; Anne M Thornton; Wendy Roeb; Kathy J Agnew; Sunday M Stray; Anneka Wickramanayake; Barbara Norquist; Kathryn P Pennington; Rochelle L Garcia; Mary-Claire King; Elizabeth M Swisher
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

2.  Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.

Authors:  Dorina M van der Kolk; Geertruida H de Bock; Beike K Leegte; Michael Schaapveld; Marian J E Mourits; Jakob de Vries; Annemieke H van der Hout; Jan C Oosterwijk
Journal:  Breast Cancer Res Treat       Date:  2010-03-04       Impact factor: 4.872

3.  Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).

Authors:  Claudia Allemani; Hannah K Weir; Helena Carreira; Rhea Harewood; Devon Spika; Xiao-Si Wang; Finian Bannon; Jane V Ahn; Christopher J Johnson; Audrey Bonaventure; Rafael Marcos-Gragera; Charles Stiller; Gulnar Azevedo e Silva; Wan-Qing Chen; Olufemi J Ogunbiyi; Bernard Rachet; Matthew J Soeberg; Hui You; Tomohiro Matsuda; Magdalena Bielska-Lasota; Hans Storm; Thomas C Tucker; Michel P Coleman
Journal:  Lancet       Date:  2014-11-26       Impact factor: 79.321

Review 4.  Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.

Authors:  Diana M Eccles; Judith Balmaña; Joe Clune; Birgit Ehlken; Annegret Gohlke; Ceri Hirst; Danielle Potter; Claudia Schroeder; Jerzy E Tyczynski; Encarnacion B Gomez Garcia
Journal:  Adv Ther       Date:  2016-01-25       Impact factor: 3.845

5.  Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.

Authors:  Simone Maistro; Natalia Teixeira; Giselly Encinas; Maria Lucia Hirata Katayama; Vivian Dionisio Tavares Niewiadonski; Larissa Garcia Cabral; Roberto Marques Ribeiro; Nelson Gaburo Junior; Ana Carolina Ribeiro Chaves de Gouvêa; Dirce Maria Carraro; Ester Cerdeira Sabino; Maria Del Pilar Estevez Diz; Roger Chammas; Geertruida Hendrika de Bock; Maria Aparecida Azevedo Koike Folgueira
Journal:  BMC Cancer       Date:  2016-12-03       Impact factor: 4.430

6.  Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry.

Authors:  Gabriela C Fernandes; Rodrigo A D Michelli; Henrique C R Galvão; André E Paula; Rui Pereira; Carlos E Andrade; Paula S Felicio; Cristiano P Souza; Deise R P Mendes; Sahlua Volc; Gustavo N Berardinelli; Rebeca S Grasel; Cristina S Sabato; Danilo V Viana; Edmundo C Mauad; Cristovam Scapulatempo-Neto; Banu Arun; Rui M Reis; Edenir I Palmero
Journal:  Oncotarget       Date:  2016-12-06
  6 in total
  1 in total

1.  Clinical Cancer Genetics in a Lower-Middle Income Country: Considerations for Policymaking.

Authors:  Ophira Ginsburg; Steven A Narod
Journal:  J Glob Oncol       Date:  2018-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.